Iovance Biotherapeutics, Inc.
GB ˙ LSE ˙ US4622601007
4,24 USD ↓ -0,14 (-3,20%)
2026-06-05
CENA AKCJI
SecurityGB:0JDK / Iovance Biotherapeutics, Inc.
InstitutionJanus Henderson Group Plc
Latest Disclosed Ownership141,672 shares
Latest Disclosed Value $ 497,977
Janus Henderson Group Plc reports 55.10% increase in ownership of 0JDK / Iovance Biotherapeutics, Inc.

On May 18, 2026 - Janus Henderson Group Plc filed a 13F-HR/A form disclosing ownership of 141,672 shares of Iovance Biotherapeutics, Inc. (GB:0JDK) valued at $502,737 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 91,341 shares of Iovance Biotherapeutics, Inc.. This represents a change in shares of 55.10% during the quarter. The current value of the position is $600,689 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-18 2026-03-31 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 141,672 50,331 55.10 498 99.60 0.0001
2026-05-15 2026-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 141,672 50,331 55.10 498 99.60 0.0001
2026-02-17 2025-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 0 0.00 250 25.76 0.0001
2025-11-14 2025-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 0 0.00 199 26.92 0.0001
2025-08-14 2025-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 0 0.00 157 -51.85 0.0001
2025-05-15 2025-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 0 0.00 325 -52.14 0.0002
2025-02-14 2024-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 0 0.00 677 -21.00 0.0003
2024-11-14 2024-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 0 0.00 857 17.24 0.0004
2024-08-14 2024-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 91,341 -1,131 -1.22 731 -46.60 0.0004
2024-05-15 2024-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 92,472 -15 -0.02 1,369 82.29 0.0007
2024-02-14 2023-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 92,487 -50 -0.05 751 78.38 0.0004
2023-11-14 2023-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 92,537 88 0.10 422 -35.23 0.0003
2023-08-14 2023-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 92,449 39,821 75.67 650 102.49 0.0004
2023-05-15 2023-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 52,628 28,584 118.88 321 109.80 0.0002
2023-02-14 2022-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 24,044 -1 -0.00 154 -33.77 0.0001
2023-01-13 2022-09-30 13F/A-1 IOVANCE BIOTHERAPEUTICS COM 462260100 24,045 -24 -0.10 231 -12.83 0.0002
2022-11-14 2022-09-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 24,045 -24 231 0.0001
2022-08-15 2022-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 24,069 68 0.28 265 -33.58 0.0002
2022-05-16 2022-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 24,001 16 0.07 399 -12.88 0.0002
2022-02-14 2021-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 23,985 23,985 458 0.0002
2021-08-16 2021-06-30 13F IOVANCE BIOTHERAPEUTICS COM 462260100 0 -78,211 -100.00 0 -100.00
2021-05-17 2021-03-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 78,211 60,207 334.41 2,476 196.88 0.0011
2021-02-16 2020-12-31 13F IOVANCE BIOTHERAPEUTICS COM 462260100 18,004 18,004 834 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.